APA (7th ed.) Citation

A, D., R, C., S, S., P, F., A, N., T, C., . . . SC, R. (2005). Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer. Investigational new drugs, 23(6), 563. https://doi.org/10.1007/s10637-005-0754-6

Chicago Style (17th ed.) Citation

A, Dowlati, et al. "Randomized Phase II Trial of Different Schedules of Administration of Rebeccamycin Analogue as Second Line Therapy in Non-small Cell Lung Cancer." Investigational New Drugs 23, no. 6 (2005): 563. https://doi.org/10.1007/s10637-005-0754-6.

MLA (9th ed.) Citation

A, Dowlati, et al. "Randomized Phase II Trial of Different Schedules of Administration of Rebeccamycin Analogue as Second Line Therapy in Non-small Cell Lung Cancer." Investigational New Drugs, vol. 23, no. 6, 2005, p. 563, https://doi.org/10.1007/s10637-005-0754-6.